site stats

Cytokinetics ceo

WebOct 22, 2024 · At the time of writing, our data shows that Cytokinetics, Incorporated has a market capitalization of US$1.1b, and reported total annual CEO compensation of US$3.5m for the year to December 2024.

Eric Terhaerdt - Senior Vice President, Development

WebApr 12, 2024 · Cytokinetics, Incorporated has a 1 year low of $32.96 and a 1 year high of $55.80. Cytokinetics (NASDAQ:CYTK – Get Rating) last posted its earnings results on Wednesday, March 1st. The ... WebCytokinetics develops muscle activators and muscle inhibitors to improve muscle function in patients with cardiovascular and neuromuscular diseases. [3] [4] In 2004 the company … chinese home decoration items https://thenewbargainboutique.com

Cytokinetics Announces COURAGE-ALS Met Criteria for …

WebNov 18, 2024 · Based on our data team's research, Robert I. Blum is the Cytokinetics's CEO. Cytokinetics has 130 employees, of which 42 are in a leadership position. Here are … WebMar 29, 2024 · Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) CEO Robert I. Blum sold 12,500 shares of the stock in a transaction dated Tuesday, March 28th. The stock was sold at an average price of $35 ... WebApr 13, 2024 · In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday, March 28th. The stock was sold at an average price of $35.05, for a total transaction of $438,125.00. Following the completion of the sale, the chief executive officer now owns 441,058 shares in the company, valued at ... chinese home cooked meal

Robert Blum, President and CEO of Cytokinetics

Category:Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q1 2024 …

Tags:Cytokinetics ceo

Cytokinetics ceo

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at …

WebOct 27, 2024 · Cytokinetics CEO: Why It's OK Not Being An Overnight Success Investors Business Daily Oct. 27, 2024, 05:02 PM Nobody will accuse Cytokinetics (CYTK) of … WebMar 31, 2024 · The company in the coming months will assess measures needed for the development of its neuromuscular pipeline, Cytokinetics CEO Robert Blum said in a statement. ALS, also known as Lou Gehrig’s disease, breaks down nerve cells in the brain and spinal cord that make muscles work, leading to progressive paralysis and death.

Cytokinetics ceo

Did you know?

WebAug 12, 2024 · August 12th, 2024, 1:08 PM PDT. Robert Blum, President and CEO at Cytokinetics discusses his company outlook. He speaks with David Ingles on "Bloomberg Daybreak: Asia". (Source: Bloomberg) Web2 days ago · Cytokinetics will seek international approval for drug following FDA rejection, says CEO Robert Blum Cytokinetics President and CEO Robert Blum joins 'Power Lunch' to discuss the FDA's rejection of the company's heart failure drug, how FDA approval increases shareholder value and future treatment pla...

WebMar 31, 2024 · Cytokinetics to Host Conference Call and Webcast Today at 8:30 am Eastern Time. SOUTH SAN FRANCISCO, Calif., March 31, ... Cytokinetics’ CEO and … WebJan 10, 2024 · Cytokinetics’ CEO, Robert I. Blum, commented, “These corporate development transactions continue our history of monetizing our leadership in muscle biology through creative deal making and ...

WebMar 31, 2024 · Cytokinetics Diane Weiser Senior Vice President, Corporate Communications, Investor Relations (415) 290-7757 Source: Cytokinetics, Incorporated … WebMar 31, 2024 · Cytokinetics drug reldesemtiv has failed a pivotal clinical trial in amyotrophic lateral sclerosis. The small molecule had previously failed in Phase 2, but the biotech believed adjustments could ...

WebMay 5, 2024 · Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q1 2024 Earnings Conference Call May 4, 2024 4:30 PM ETCompany ParticipantsDiane Weiser - SVP of Corporate Communications and IRRobert Blum -...

WebCytokinetics's President, Chief Executive Officer and Director is Robert I Blum. Other executives include Daniel R Casper, Vice President, Information Technology; Andrew … chinese home delivery bendigoWebNov 10, 2024 · Robert hopes Cytokinetics will be remembered as a company that ensures patients have equitable access to the medicines that it’s developing, as well as for being a truly innovative organization that … grand national assembly of turkeyWebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate grand national bank marblehead maWebMar 31, 2024 · Cytokinetics’ ALS research has revolved around “troponin,” a protein involved in muscle movement, with the idea being that activating this protein may help treat the disease. The company’s first attempt at this resulted in an experimental medicine called tirasemtiv, but it was shelved after missing the primary goal of a late-stage study ... grand national betWebPresident And Chief Executive Officer Andrew Callos EVP, Chief Commercial Officer Daniel R. Casper VP, Information Technology Bonnie A. Charpentier, Ph.D. SVP, Regulatory Affairs and Compliance Steven M. Cook SVP, Commercial Supply Chain … Vision 2024: Empowering Our Future. Vision 2025. Vision 2025: “Leading with … Robert has served as our President and Chief Executive Officer of Cytokinetics … Cytokinetics is a late-stage biopharmaceutical company focused on … grand national betting paddy powerWebMay 7, 2024 · Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ETCompany ParticipantsDiane Weiser – Senior Vice President-Corporate Communications and... grand national betting odds william hillWebNov 10, 2024 · In 2007, I became both President and CEO.” Cytokinetics is a leader in a specific area of biology focused on the discovery, development and commercialization of new medicines that modulate the mechanics of … grand national betting authority